Redwood City, CA, United States of America

F Anthony Romero

This inventor holds 42 USPTO granted patents and 28 published patent applications, plus 2 CIPO patents and 23 EPO patents, primarily in Therapeutic Compounds. Top assignees: Genentech, Inc., Constellation Pharmaceuticals, Inc., Terns Pharmaceuticals, Inc.. Active years: 2012-2026.

USPTO Granted Patents = 42 (Patent Applications = 28)

% Patents Active = 92.9

CIPO Patents = 2 (Patent Applications = 17)

EPO Patents = 23 (Patent Applications = 45)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 62(Granted Patents)

Location History:

Westfield, NJ (US) (2012 - 2013)
Brisbane, CA (US) (2019 - 2021)
South San Francisco, CA (US) (2017 - 2022)
Redwood City, CA (US) (2014 - 2024)

Company Filing History:

Constellation Pharmaceuticals, Inc.

patents

11 out of 13

Terns Pharmaceuticals, Inc.

patents

4. 5 out of 2,405

Merck Sharp + Dohme Corp.

Metabasis Therapeutics, Inc.

patents

7. 2 out of 20

Oric Pharmaceuticals, Inc.

patents

8. 2 out of 41

Unity Biotechnology, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

JAK Kinase Inhibitors

GLP-1R Agonists

Thyroid Hormone Receptor

Polo Like Kinase 4

Peptide-based Inhibitors

Pyrazolopyrimidine

Benzamide Intermediates

Spiroxazolidinone

Cyclic Benzimidazole

Cancer Treatment

Leukemia Treatment

Anti-diabetic Agents

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528812 - Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof (2026-01-20),

2. 12528791 - Thyroid hormone receptor beta agonist compounds (2026-01-20),

3. 12522596 - Compounds as GLP-1R agonists (2026-01-13),

4. 12486261 - Compounds as GLP-1R agonists (2025-12-02),

5. 12454524 - (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias (2025-10-28),

6. 12398127 - Thyroid hormone receptor beta agonist compounds (2025-08-26),

7. 12378239 - Compounds as GLP-1R agonists (2025-08-05),

8. 12378238 - Compounds as GLP-1R agonists (2025-08-05),

9. 12378237 - Compounds as GLP-1R agonists (2025-08-05),

10. 12378236 - Compounds as GLP-1R agonists (2025-08-05),

11. 12312339 - Polo like kinase 4 inhibitors (2025-05-27),

12. 12247032 - Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases (2025-03-11),

13. 12240835 - Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity (2025-03-04),

14. 12024507 - Compounds as GLP-1R agonists (2024-07-02),

15. 11858915 - Polo like kinase 4 inhibitors (2024-01-02),

Title: The Innovative Journey of F Anthony Romero

Introduction: F Anthony Romero, a visionary inventor based in Redwood City, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: F Anthony Romero holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, F Anthony Romero has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, F Anthony Romero has collaborated with leading research institutions and tech companies to bring his ideas to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: F Anthony Romero's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.